Aktive Positionen von Emma Beausang
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GH RESEARCH PLC | General Counsel | - | - |
Karriereverlauf von Emma Beausang
Ehemalige bekannte Positionen von Emma Beausang
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AERIE PHARMACEUTICALS, INC. | General Counsel | - | 01.12.2021 |
Ausbildung von Emma Beausang
| University of Strathclyde | Undergraduate Degree |
| UCL School of Pharmacy | Doctorate Degree |
Statistik
International
| Vereinigtes Königreich | 3 |
| Vereinigte Staaten | 2 |
| Irland | 2 |
Operativ
| General Counsel | 2 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GH RESEARCH PLC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
- Börse
- Insiders
- Emma Beausang
- Erfahrung
